We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+25.57%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$25.4B
AUM Growth
+$5.37B
Cap. Flow
+$508M
Cap. Flow %
2%
Top 10 Hldgs %
19.14%
Holding
1,320
New
149
Increased
490
Reduced
420
Closed
99

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$82.6M
2
AMZN icon
Amazon
AMZN
+$51.1M
3
EBAY icon
eBay
EBAY
+$50.4M
4
NFLX icon
Netflix
NFLX
+$45.5M
5
RTX icon
RTX Corp
RTX
+$36.9M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$190M
2
MA icon
Mastercard
MA
+$48.9M
3
RTN
Raytheon Company
RTN
+$44.4M
4
PEP icon
PepsiCo
PEP
+$43.1M
5
SPGI icon
S&P Global
SPGI
+$42M

Sector Composition

Rank Sector Weight
1 Technology 28.14%
2 Healthcare 19.28%
3 Consumer Discretionary 11.02%
4 Financials 10.21%
5 Industrials 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
A icon
326
Agilent Technologies
A
$39.6B
$15.8M 0.06%
178,868
-12,473
-7% -$1.02M
EXAS
327
DELISTED
Exact Sciences
EXAS
$15.8M 0.06%
181,272
+47,454
+35% +$3.79M
VNO icon
328
Vornado Realty Trust
VNO
$7.65B
$15.8M 0.06%
412,478
+29,400
+8% +$1.14M
CB icon
329
Chubb
CB
$140B
$15.6M 0.06%
123,375
-2,961
-2% -$343K
UTHR icon
330
United Therapeutics
UTHR
$26.1B
$15.4M 0.06%
127,574
+44,167
+53% +$4.97M
NDAQ icon
331
Nasdaq
NDAQ
$53.4B
$15.4M 0.06%
387,513
+6,522
+2% +$243K
ZNGA
332
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$15.4M 0.06%
1,610,900
+1,354,400
+528% +$11.1M
BALL icon
333
Ball Corp
BALL
$17.5B
$15.2M 0.06%
218,946
-5,716
-3% -$386K
ARNA
334
DELISTED
Arena Pharmaceuticals Inc
ARNA
$15.2M 0.06%
241,248
+93,461
+63% +$5.14M
WFC icon
335
Wells Fargo
WFC
$254B
$15.1M 0.06%
589,559
+62,375
+12% +$1.71M
PLNT icon
336
Planet Fitness
PLNT
$4.45B
$15M 0.06%
247,627
-8,546
-3% -$513K
ROST icon
337
Ross Stores
ROST
$80.8B
$14.8M 0.06%
174,025
-69,384
-29% -$6.29M
MSM icon
338
MSC Industrial Direct
MSM
$6.76B
$14.8M 0.06%
203,700
-500
-0.2% -$32.2K
TT icon
339
Trane Technologies
TT
$98.8B
$14.8M 0.06%
166,535
+34,642
+26% +$3.01M
LHCG
340
DELISTED
LHC Group LLC
LHCG
$14.7M 0.06%
+84,206
New +$12.4M
IVZ icon
341
Invesco
IVZ
$12.4B
$14.6M 0.06%
1,353,798
+488,725
+56% +$4.38M
STLA icon
342
Stellantis
STLA
$17.4B
$14.5M 0.06%
1,419,482
+70,627
+5% +$611K
GS icon
343
Goldman Sachs
GS
$289B
$14.4M 0.06%
72,912
+5,324
+8% +$999K
RMD icon
344
ResMed
RMD
$31.1B
$14.3M 0.06%
74,493
+54,295
+269% +$8.88M
WHR icon
345
Whirlpool
WHR
$2.49B
$14.3M 0.06%
110,368
+383
+0.3% +$43.8K
YUM icon
346
Yum! Brands
YUM
$41.9B
$14.2M 0.06%
163,140
-116,848
-42% -$9.98M
EMN icon
347
Eastman Chemical
EMN
$7.69B
$14.2M 0.06%
203,600
+41,806
+26% +$2.63M
FRC
348
DELISTED
First Republic Bank
FRC
$14.1M 0.06%
133,154
+123,717
+1,311% +$12.7M
HASI icon
349
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.81B
$14M 0.06%
493,484
+156,209
+46% +$4.27M
PPG icon
350
PPG Industries
PPG
$24.9B
$14M 0.06%
132,408
-13,660
-9% -$1.32M

Similar funds

Axa's Q2 2020 Portfolio in Review

As of Q2 2020, Axa held 1,320 positions worth $25.4B, up 27% from $20B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q2 2020 filing shows 149 new, 490 increased, 420 reduced and 99 closed positions. Its largest new stake was Exelixis: 820,990 shares worth $19.5M. The largest sale was Linde, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2020 buy was Exelixis: 820,990 shares worth $19.5M.
  • Axa added most to Microsoft in Q2 2020, an estimated $82.6M increase.
  • Axa's biggest Q2 2020 reduction was Linde, cutting an estimated $190M.
  • Axa fully exited Raytheon Company in Q2 2020, selling an estimated $44.4M.
  • Axa's ten largest holdings make up 19% of its $25.4B portfolio in Q2 2020.
  • Axa opened 149 new positions and closed 99 in Q2 2020.
  • Axa's portfolio value rose 27% quarter-over-quarter to $25.4B.

Based on Axa's 13F filing for Q2 2020, filed 14 Aug 2020.